CN Patent

CN103239452A — 一种溴甲基纳曲酮药物组合物

Assigned to LIAONING MILLION BIOMEDICAL TECHNOLOGY Co Ltd · Expires 2013-08-14 · 13y expired

What this patent protects

本发明涉及一种安全性高的溴甲基纳曲酮的药物组合物，具体包括溴甲基纳曲酮和式Ⅱ、式Ⅲ所示结构化合物。本发明进一步分离、纯化和表征了溴化甲基纳曲酮相关物质的结构和活性，发现式Ⅱ，式Ⅲ所示结构化合物是引起溴化甲基纳曲酮药物胃肠道不良反应的主要物质。 式Ⅱ 式Ⅲ

USPTO Abstract

本发明涉及一种安全性高的溴甲基纳曲酮的药物组合物，具体包括溴甲基纳曲酮和式Ⅱ、式Ⅲ所示结构化合物。本发明进一步分离、纯化和表征了溴化甲基纳曲酮相关物质的结构和活性，发现式Ⅱ，式Ⅲ所示结构化合物是引起溴化甲基纳曲酮药物胃肠道不良反应的主要物质。 式Ⅱ 式Ⅲ

Drugs covered by this patent

Patent Metadata

Patent number
CN103239452A
Jurisdiction
CN
Classification
—
Expires
2013-08-14
Drug substance claim
No
Drug product claim
No
Assignee
LIAONING MILLION BIOMEDICAL TECHNOLOGY Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.